Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children

NCT03447782 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT03447782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03447782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children
Lead sponsor
Boston Children's Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
July 23, 2018
Completion date
November 20, 2020
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

new daily persistent headache (ndph)